DBV Technologies clinical trials
DBV Technologies is the lead sponsor of 3 current clinical trials in our Ireland, USA, UK, France, Spain, Netherlands, Canada, Australia and Germany registers. None of its ClinicalTrials.gov trials is recruiting at the moment. All registered phases are Phase 3. The most-studied condition is Peanut Allergy.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by DBV Technologies
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
NCT07003919 · Allergy, Peanut Allergy
|
Phase 3 | Active, closed | 2025-06 | Ireland, UK, USA, France, Spain, Netherlands, Canada, Australia |
|
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
NCT05741476 · Allergy, Peanut
|
Phase 3 | Active, closed | 2023-02 | Ireland, UK, USA, Germany, France, Spain, Netherlands, Canada, Australia |
|
Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
NCT03013517 · Peanut Allergy
|
Phase 3 | Active, closed | 2017-01 | Ireland, USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in DBV Technologies trials
3 conditionsBy trial register
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Peanut Allergy
| Sponsor | Trials |
|---|---|
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 3 |
| Allergy Therapeutics | 1 |
Sponsors with the most current trials registered for this condition.
Questions about DBV Technologies trials
How many clinical trials does DBV Technologies sponsor?
DBV Technologies is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Ireland, USA, UK, France, Spain, Netherlands, Canada, Australia and Germany registers, as of the registry sync on 10 October 2026. Completed and withdrawn studies are not counted.
Are DBV Technologies trials recruiting?
Not at the moment. None of its 3 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Does DBV Technologies have clinical trials in Ireland?
Yes. 3 trials in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.